Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D4HM0Y
|
|||
| Drug Name |
BVL-GSK098
|
|||
| Drug Type |
Small molecule
|
|||
| Indication | Pulmonary tuberculosis [ICD-11: 1B10.Z] | Phase 2 | [1] | |
| Company |
GlaxoSmithKline
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05473195) A Phase 2 Trial to Evaluate the EBA, Safety and Tolerability of Ethionamide Alone and in Combination With BVL-GSK098 Administered Orally to Adults With Newly Diagnosed, Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.